Chemotherapy-Induced Changes in Cardiac Capillary Permeability Measured by Fluorescent Multiple Indicator Dilution
- 191 Downloads
Anthracyclines cause severe irreversible cardiac toxicity. The study of changes in cardiac permeability with chemotherapy could enhance the understanding of mechanisms behind cardiac damage, and provide useful information to evaluate anthracycline cardiotoxicity. Thirty-six rats (12 Sprague–Dawley, 12 Wistar, 12 Fischer-344) were randomly assigned to control (n = 21) or doxorubicin (n = 15), and injected i.p. with a cumulative dose of 18 mg/kg doxorubicin in saline (vehicle) or vehicle alone over 12 days. Echocardiography was performed at baseline and on day 11. An isolated heart experiment was done on day 12 to obtain perfused heart pressure values, and to measure cardiac capillary permeability using a Texas Red/sodium fluorescein multiple indicator dilution method. Control animals had significantly lower average permeability-surface-area-products (0.035 ± 0.013 cm3/s) than doxorubicin animals (0.066 ± 0.023 cm3/s), PSP ± SD, p < 0.001. These permeability changes correlated with significant functional changes. There was a significant decline in cardiac function with a deleterious effect of chemotherapy on fractional shortening (p < 0.001), left ventricular developed pressure (p < 0.001), contractility (p < 0.001), and relaxation (p = 0.02). Based on our results, cardiac capillary permeability changes can be detected after in vivo chemotherapy treatment using our fluorescent multiple indicator dilution technique, and may provide valuable information in evaluating cardiotoxicity of novel drugs.
KeytermsCardiotoxicity Doxorubicin Endothelial damage Fluorescence
Aortic pressure (mmHg)
Fractional shortening (%)
Interventricular septum thickness in diastole (mm)
Interventricular septum thickness in systole (mm)
Left ventricular diameter in diastole (mm)
Left ventricular developed pressure (mmHg)
Left ventricular diameter in systole (mm)
Left ventricular end diastolic pressure (mmHg)
Left ventricular pressure (mmHg)
Left ventricular posterior wall thickness in diastole (mm)
Left ventricular posterior wall thickness in systole (mm)
Permeability-surface-area-product (cm3 s−1)
Texas Red-conjugated Dextran
Time to peak (s)
Laboratory work was conducted using the facilities of the Biomedical Engineering Department at Florida International University. A. F. F. was supported by NIH/NIGMS R25 GM061347 during completion of a portion of this work. The same Grant also provided partial experimental funding through the 2008 Biomedical Research Initiative Summer Research Award. D. A. C. was supported by the FIU BME Norman R. Weldon Undergraduate Summer Research Internship during completion of a portion of this work.
- 1.American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society, 2014.Google Scholar
- 11.Fernandez-Fernandez, A., A. J. McGoron, and D. A. Carvajal. Application of a fluorescent multiple indicator dilution method to study changes in cardiac capillary permeability with chemotherapy. Paper presented at: IFMBE Proceedings 25th Southern Biomedical Engineering Conference 2009; Miami, FL.Google Scholar
- 12.Fernandez-Fernandez, A., D. A. Carvajal, and A. J. McGoron. Measuring in vivo effects of chemotherapy treatment on cardiac capillary permeability. Paper presented at: IFMBE Proceedings 26th Southern Biomedical Engineering Conference 2010; College Park, MD.Google Scholar
- 17.McGoron, A. J., M. C. Gerson, D. S. Biniakiewicz, N. J. Roszell, L. C. Washburn, and R. W. Millard. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia. Eur. J. Nucl. Med. 24(12):1479–1486, 1997.PubMedCrossRefGoogle Scholar
- 25.de Nigris, F., M. Rienzo, C. Schiano, C. Fiorito, A. Casamassimi, and C. Napoli. Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart. Eur. J. Cancer. 44(3):334–340, 2008.PubMedCrossRefGoogle Scholar
- 27.Carvajal, D. A., A. Fernandez-Fernandez, and A. J. McGoron. Development of Matlab algorithm to process pressure waveforms from isolated perfused heart experiments. Paper presented at: IFMBE Proceedings 25th Southern Biomedical Engineering Conference 2009; Miami, FL.Google Scholar
- 29.Boston University. Tumor Policy for Mice and Rats. Section IX: Humane Endpoint Criteria. Available at: http://www.bu.edu/orccommittees/iacuc/policies-and-guidelines/tumor-policy-for-mice-and-rats/, 2009.
- 30.University of Pennsylvania. IACUC Guideline: Humane Intervention and Endpoints for Laboratory Animal Species. Available at http://www.upenn.edu/regulatoryaffairs/Documents/iacuc/guidelines/iacucguideline-humaneendpoints-8%2023%2011.pdf, 2011.
- 38.Bassingthwaighte, J., C. A. Goresky, and J. H. Linehan. Modeling in the analysis of the processes of uptake and metabolism in the whole organ. In: Whole Organ Approaches to Cellular Metabolism, edited by Bassingthwaighte et al. Springer, 1998, pp. 3–27.Google Scholar
- 42.Schwarz, E. R., C. Pollick, W. P. Meehan, and R. A. Kloner. Evaluation of cardiac structures and function in small experimental animals: transthoracic, transesophageal, and intraventricular echocardiography to assess contractile function in rat heart. Basic Res. Cardiol. 93(6):477–486, 1998.PubMedCrossRefGoogle Scholar